EIM
ANGO icon

Essex Investment Management’s AngioDynamics ANGO Stock Holding History

Essex Investment Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-360,544
Closed -$4.63M – 308
2025
Q4 		$4.63M Buy
360,544
+33,148
+10% +$409K 0.71% 45
2025
Q3 		$3.66M Buy
327,396
+96,639
+42% +$933K 0.56% 60
2025
Q2 		$2.29M Buy
230,757
+51,567
+29% +$505K 0.42% 98
2025
Q1 		$1.68M Buy
+179,190
New +$1.88M 0.35% 118

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $295M AUM 19.08% 1-Year Est. Return

Essex Investment Management's ANGO Position: Q1 2026 in Review

Essex Investment Management sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 360,544 shares — an estimated $4.63M sold.

Essex Investment Management first reported a position in ANGO in Q1 2025 and held it in 4 quarters. The position peaked at $4.63M in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Essex Investment Management reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
  • Essex Investment Management sold 360,544 AngioDynamics shares in Q1 2026, an estimated $4.63M.
  • Essex Investment Management first reported a position in AngioDynamics in Q1 2025 and held it in 4 quarters.
  • Essex Investment Management's AngioDynamics position peaked at $4.63M in Q4 2025.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Essex Investment Management's 13F filing for Q1 2026, filed 11 May 2026.